Determinants of the use of complementary therapies by patients with cancer

被引:167
作者
Paltiel, O
Avitzour, M
Peretz, T
Cherny, N
Kaduri, L
Pfeffer, RM
Wagner, N
Soskolne, V
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Social Med, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Sch Publ Hlth, Dept Hematol, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Ctr, Sch Publ Hlth, Dept Oncol, IL-91120 Jerusalem, Israel
[4] Chaim Sheba Med Ctr, Dept Oncol, IL-52621 Tel Hashomer, Israel
关键词
D O I
10.1200/JCO.2001.19.9.2439
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We performed a survey of Israeli oncology patients to examine the extent of their use of complementary therapies (CT) and to compare sociodemographic, psychologic, and medical characteristics, attitudes, and quality of life of users and nonusers of CT. Patients and Methods: Questionnaires were administered to 1,027 patients attending ambulatory and inpatient hematology or oncology facilities at three hospitals. Medical information was extracted from charts. Univariate and multivariate comparisons of users and nonusers of CT were performed. Results: A total of 526 participants (51.2%) had used CT since their diagnosis, and 357 patients (34.9%) had used CT recently (in the past 3 months). Factors that multivariate analysis found to be significantly associated (P < .05) with recent CT use were as follows: female sex; age 35 to 59 years; more education; coming to the hospital by private car; advanced disease status; having a close friend or a relative with cancer; and attending support groups or individual counseling. After controlling for these factors, individually examined psychosocial variables associated with recent CT use included the following (odds ratios [OR] with 95% confidence intervals [CI]): needs unmet by conventional medicine (OR, 2.76; 95% CI, 1.95 to 3.89); helplessness (OR, 1.39; 95% CI, 1.0 to 1.91); incomplete trust in the doctor (OR, 1.49; 95% CI, 1.08 to 2.06); and changed outlook or beliefs since the diagnosis of cancer (OR, 1.47; 95% CI, 1.07 to 2.02). Functional quality of life (including physical, emotional, social, and role function) and symptom (fatigue and diarrhea) scores were significantly worse for recent CT users compared with nonusers, controlling for age, sex, and current disease status. Conclusion: Characteristics associated with CT use include age, sex, education, and advanced disease. Significant associations between CT use and attending supportive psychotherapy, unmet needs, helplessness, and worse emotional and social function indicate considerable distress, suggesting that increased attention to psychosocial needs within oncologic settings is warranted. J Clin Oncol 19:2439-2448. (C) 2001 by American Society of Clinical Oncology.
引用
收藏
页码:2439 / 2448
页数:10
相关论文
共 39 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
AMIR A, 1994, 1 GERTN I EP HLTH PO
[3]   Alternative medicine - The risks of untested and unregulated remedies [J].
Angell, M ;
Kassirer, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :839-841
[4]   Why patients use alternative medicine - Results of a national study [J].
Astin, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1548-1553
[5]  
BAGENAL FS, 1990, LANCET, V336, P606
[6]  
BAIDER L, 1995, ISRAEL J MED SCI, V31, P179
[7]  
Bernstein Judith H., 1996, Harefuah, V130, P83
[8]   Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions [J].
Boon, H ;
Stewart, M ;
Kennard, MA ;
Gray, P ;
Sawka, C ;
Brown, JB ;
McWilliam, C ;
Gavin, A ;
Baron, RA ;
Aaron, D ;
Haines-Kamka, T .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2515-2521
[9]  
Brigden ML., 1998, ANN ROY COLL PHYSIC, V31, P9
[10]   Discussing complementary therapies with cancer patients: What should we be talking about? [J].
Burstein, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2501-2504